OpenVSafe by OpenVAERS
Search V-safe

9XK-22631-12898

3 vaccinations 3 coded responses 24 check-ins 3 free-text entries 2 call cases
Sex
Male
Age at first dose
61-65
ZIP prefix
660 / KS
Registered
2021-03-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-16
    Registered in v-safe
  2. 2021-03-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-16
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-06
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-06
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good
    Free text: Minor tenderness in the injection area with pressure applied on it.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-13
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-07-06
    Survey response — 3 months, dose 2
    MedDRA: Fluid retention, Medical counselling, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Retention of fluid, possibly involving right side of my heart. I am to have a heart cath next week to determine if my heart is actually involved. · Healthcare visit (other): Telephone conversations leading to in person visit coming up before the heart cath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-07-06
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-07-09
  27. 2021-10-06
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-29
    Dose 3 — Pfizer-BioNTech
  29. 2022-04-06
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-05-30
    Survey response — 6 months, dose 3
    MedDRA: Pre-existing disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Pre-cancer (skin) scalp. I have had two blue light treatments for it and will have a 6 month follow up appointment. · Healthcare visit (other): Blue light treatment for pre-cancer
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-05-30
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-05-31
  33. 2022-06-01
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  34. 2022-06-01
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-16Pfizer-BioNTech
22021-04-06Pfizer-BioNTech
32021-11-29Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-07

Systemic reaction (other): Minor tenderness in the injection area with pressure applied on it.

Release 9 — 3 months, dose 2

2021-07-06

Symptoms: Retention of fluid, possibly involving right side of my heart. I am to have a heart cath next week to determine if my heart is actually involved.
Healthcare visit (other): Telephone conversations leading to in person visit coming up before the heart cath

Release 11 — 6 months, dose 3

2022-05-30

Symptoms: Pre-cancer (skin) scalp. I have had two blue light treatments for it and will have a 6 month follow up appointment.
Healthcare visit (other): Blue light treatment for pre-cancer

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
HCVOOffice visit ✓ ✓ ✓
HCVOUnevaluable event · · ✓
SDFluid retention ✓ ✓ ✓
SDPre-existing disease · · ✓
SROInjection site pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release